November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
John K. Lee: First-in-human phase I/II clinical trial of STEAP1 CAR T cell therapy for mCRPC
Oct 14, 2024, 13:17

John K. Lee: First-in-human phase I/II clinical trial of STEAP1 CAR T cell therapy for mCRPC

John K. Lee posted on X:

First-in-human phase I/II clinical trial of STEAP1 CAR T cell therapy for mCRPC now open to enrollment!”

Jessica Hawley shared this post adding:

Very hopeful our STEAP1 CART from Fred Hutchinson Cancer Center makes difference for patients with advanced CRPC!

Thanks John K. Lee, Vipul Bhatia, National Cancer Institute, PromiCell for science and partnership.”
John K. Lee: First-in-human phase I/II clinical trial of STEAP1 CAR T cell therapy for mCRPC

Read Further.
Source: John K. Lee/X and Jessica Hawley/X

John K. Lee is a physician-scientist and Associate Professor-in-Residence in Hematology/Oncology and Urologic Oncology at the David Geffen School of Medicine at UCLA. He specializes in advanced prostate and bladder cancer and leads a federally funded research laboratory at the UCLA Jonsson Comprehensive Cancer Center, focusing on genotype-phenotype relationships and immune-based treatment strategies.

Jessica Hawley is a board-certified medical oncologist and clinical-translational scientist. She is an Assistant Professor at UW Medicine and Fred Hutch. Her research is centered on developing novel immunotherapies and identifying immunologic biomarkers that predict clinical responses in patients with genitourinary malignancies.